Inventage Lab

Inventage Lab Revenue per Employee

The Revenue per Employee of Inventage Lab (389470.KQ) as of Nov 4, 2026 is 44.53 M KRW. In the previous year, Revenue per Employee was 27.01 M KRW — a change of 64.83% (higher).

Revenue per Employee

44.53 MKRW

YoY

64.83%

Last updated:

Revenue per Employee of Inventage Lab is 2025 44.53 M KRW. Revenue per Employee of Inventage Lab was 2024 27.01 M KRW. It decreases by 64.83% higher compared to the previous year.

The Inventage Lab Revenue per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Employee
Date
Revenue per Employee
Jan 1, 2020
8.06 M KRW
Jan 1, 2021
28.21 M KRW
Jan 1, 2022
56.42 M KRW
Jan 1, 2023
9.97 M KRW
Jan 1, 2024
27.01 M KRW
Jan 1, 2025
44.53 M KRW
The Inventage Lab Revenue per Employee history
YEARRevenue per EmployeeYoY
44.53 MKRW+64.83%
27.01 MKRW+170.90%
9.97 MKRW-82.33%
56.42 MKRW+100.01%
28.21 MKRW+250.13%
8.06 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inventage Lab Stock analysis

What does Inventage Lab do? Inventage Lab, Inc. generates revenue through the research, manufacture, and sale of human medicines targeting male pattern baldness, dementia, and prostate cancer, as well as veterinary medicines including combination drugs and chemical castration agents. The company leverages its proprietary platforms for long-acting injections and genetic material drug delivery to develop and scale production of these products. Its human medicine segment focuses on therapeutic areas with significant market demand, while veterinary medicines serve agricultural and companion animal markets. The firm's business model centers on proprietary technology platforms applied to both human and veterinary pharmaceutical development. These platforms enable the company to create and mass-produce innovative drug delivery systems, which are critical for the efficacy of their medicine portfolios. Revenue streams are derived from direct sales of these medicines to healthcare providers and veterinary institutions within their target markets. Inventage Lab, Inc. operates with a dual focus on human and veterinary pharmaceuticals, utilizing its specialized platforms to address unmet medical needs in both sectors. The company's product range includes treatments for specific conditions like male pattern baldness and prostate cancer, alongside veterinary applications such as chemical castration agents, which are sold to relevant industry stakeholders in their respective markets. Inventage Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inventage Lab stock

Revenue per Employee of Inventage Lab is 44.53 M KRW in 2025.

Revenue per Employee of Inventage Lab changed from 27.01 M KRW to 44.53 M KRW, representing a 64.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Employee Inventage Lab since 2006 – with annual values, charts, and detailed analysis.

Revenue per employee measures workforce productivity by dividing total revenue by the number of employees. Higher values indicate more efficient operations.

Revenue per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Revenue per Employee's Inventage Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Inventage Lab

All Key Metrics — Inventage Lab